View Archive »
About The Cover
The cover for issue 92 of Oncotarget features Figure 4, "Intratumoral CD56bright NK cells are more functional than CD56dim NK cells and correlate with survival in bladder cancer," by Mukherjee, et al.
|
|
Table of Contents
News
Editorial
|
| p53 limits B cell receptor BCR signalling: a new role for miR34a and FOXP1 |
|
https://doi.org/10.18632/oncotarget.26376
|
| 36409-36410 |
|
| EpsteinBarr virus: From kisses to cancer an ingenious immune evader |
|
https://doi.org/10.18632/oncotarget.26381
|
| 36411-36412 |
Research Papers
|
| Ewing sarcoma resistance to SP2509 is not mediated through KDM1A/LSD1 mutation |
|
https://doi.org/10.18632/oncotarget.26326
|
| 36413-36429 |
|
| Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis |
|
https://doi.org/10.18632/oncotarget.26335
|
| 36430-36443 |
|
| Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer |
|
https://doi.org/10.18632/oncotarget.26342
|
| 36444-36456 |
|
| Oncostatin M is overexpressed in skin squamouscell carcinoma and promotes tumor progression |
|
https://doi.org/10.18632/oncotarget.26355
|
| 36457-36473 |
|
| Distinct mechanisms by which two forms of miR140 suppress the malignant properties of lung cancer cells |
|
https://doi.org/10.18632/oncotarget.26356
|
| 36474-36491 |
|
| Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer |
|
https://doi.org/10.18632/oncotarget.26362
|
| 36492-36502 |
|
| Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma |
|
https://doi.org/10.18632/oncotarget.26367
|
| 36503-36514 |
|
| Glyoxalase 1 gene is highly expressed in basallike human breast cancers and contributes to survival of ALDH1positive breast cancer stem cells |
|
https://doi.org/10.18632/oncotarget.26369
|
| 36515-36529 |
|
| Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma |
|
https://doi.org/10.18632/oncotarget.26370
|
| 36530-36541 |
Corrections
|
| Correction: Se2Mo10V3 a heteropoly compound containing selenium inhibits tumor growth |
|
https://doi.org/10.18632/oncotarget.26408
|
| 36542-36542 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
